Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis
Main Authors: | Jim O’Connell, Jayne Doherty, Amy Buckley, David Cormican, Cara Dunne, Karen Hartery, John Larkin, Finbar MacCarthy, Paul McCormick, Susan McKiernan, Brian Mehigan, Cian Muldoon, Ciara Ryan, Jacintha O’Sullivan, David Kevans |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of Intestinal Diseases
2022-07-01
|
Series: | Intestinal Research |
Online Access: | http://irjournal.org/upload/pdf/ir-2021-00073.pdf |
Similar Items
-
Current targeted therapies in the treatment of advanced colorectal cancer: a review
by: Andrew Moriarity, et al.
Published: (2016-07-01) -
Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis
by: Liang Han, et al.
Published: (2023-11-01) -
Historical evolution of strategic management /
by: McKiernan, Peter
Published: (1996) -
Invisible Hand(s): Quality Assurance in the Age of Author Self-Archiving
by: McKiernan Gerry
Published: (2003-09-01) -
Adipocyte Oncostatin Receptor Regulates Adipose Tissue Homeostasis and Inflammation
by: David Sanchez-Infantes, et al.
Published: (2021-03-01)